BIBLIOGRAFIA 1. Beaglehole R, Bonita R, Horton R et al.; for The Lancet NCD Action Group and the NCD Alliance. Priority actions for the noncommunicable disease crisis. Lancet 2011; 377:1438–1447. 2. World Health Organization. Global burden of disease. 2012. Available from:http://www.who.int/topics/global _burden_of_ disease/en/ (accessed 6 March 2012) 3. World Health Organization. Global burden of disease. Preventing chronic diseases: a vital investment. 2005. Available from: http://www.who.int/chp/ chronic_disease_report/full_ report.pdf (accessed 6 March 2005 4. World Health Organization. Gaining Health: The European Strategy for the Prevention and Control of Noncommunicable Diseases. 2006. Available from: http://www.euro.who. int/__data/assets/pdf_file/0008/76526/E89306.pdf (accessed 6 March 2012).
16. Internatinal Diabetes Federation. Global Diabetes Plan 20112021. 2011. Available from: http://www.idf.org/globaldiabetes-plan-2011-2021 (accessed 6 March 2012). 17. International Diabetes Federation. IDF Diabetes Atlas, 5th ed. Brussels, Belgium: International Diabetes Federation, 2011. 18. Busse R, Blümel M & Scheller-Kreinsen D. Tackling chronic disease in Europe: strategies, interventions and challenges. 2010. Available from: http://www. euro.who.int/__ data/assets/pdf_file/0008/96632/E93736.pdf (accessed 6 March 2012). 19. International Diabetes Federation. A Call to Action on Diabetes. 2010. Available from: http://www.idf.org/webdata/ Call-to-Action-on-Diabetes.pdf (accessed 6 March 2012).
5. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New England Journal of Medicine 2003; 348:383–393.
20. Tal på diabetes 1996-2010, Sundhedsstyrelsen 2011.
6. United Nations. General Assembly. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Noncommunicable Diseases. 2011. Available from: http://www.un.org/en/ga/ ncdmeeting2011/ (accessed 6 March 2012).
22. European Commission. Sustainable development in the European Union. 2011. Available from: http://epp.eurostat. ec.europa.eu/portal/page/portal/ product_details/publication? p_product_code=KS-31-11-224 (accessed 6 March 2012).
7. World Health Organization. First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control. Discussion paper: Prevention and control of NCDs: priorities for investment. 2011. Available from: http://www.who.int/nmh/publications/who_bestbuys_to_preven t_ncds. pdf (accessed 6 March 2012).
21. Green, A.: Diabetes Mellitus i Danmark 1997-2006. Epidemiologiske Analyser
23. Davis TM. Ethnic diversity in type 2 diabetes. Diabet Med 2008; 25[(Suppl. 2)]: 52-56. 24. World Health Organization. Adherence to long-term therapies: Evidence for action. 2003 Available from: http://whqlibdoc.who.int/ publications/2003/9241545992.pdf (accessed 6 March 2012).
8. United Nations. High-level Meeting on Non-communicable Diseases. 2011. Available from: http://www.un.org/en/ ga/president/65/issues/ncdiseases.shtml (accessed 6 March 2012).
25. Varo JJ, Martinez-Gonález MA, Irala-Estévez J et al. Distribution and determinants of sedentary lifestyles in the European Union. International Journal of Epidemiology 2003; 32:138–146.
9. Lindström J, Neumann A, Sheppard KE et al.; on behalf of the IMAGE Study Group. Take action to prevent diabetes - the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Hormone and Metabolic Research 2010; 42:S37–S57.
26. World Health Assembly. WHO global strategy on diet, physical activity and health. 2004. Available from: http://www.who.int/dietphysicalactivity/ strategy/eb11344/ strategy_english_web.pdf(accessed 6 March 2012).
10. Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 2001; 344:1343–1350.
27. Elmadfa I & Freisling H. Nutritional status in Europe: methods and results. Nutrition Reviews 2009; 67(Suppl. 1):S130–S134.
11. Knowler W, Barrett-Connor E, Fowler S et al.; Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med 2002; 346[6]:393-403. 12. Lindström J, Ilanne-Parikka P, Peltonen M et al.; on behalf of the Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: the follow-up results of the Finnish Diabetes Prevention Study. Lancet 2006; 368:1673–1679.
182
15. Alberti KGMM, Zimmet P & Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabetic Medicine 2007; 24:451–463.
28. Schwarz PE, Greaves CJ, Lindström J et al. Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nature Reviews Endocrinology 2012; doi:10.1038/nrendo.2011.232. 29. Malnick S, Knobler H. The Medical Complications of Obesity. QJM 2006; 99[9]:565-579. 30. Abdullah A, Peeters A, de Courten M et al. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Research and Clinical Practice 2010; 89:309–319.
13. Paulweber B, Valensi P, LindströmJ et al.; for the Writing Group on behalf of the IMAGE Study Group. A European evidence-based guideline for the prevention of type 2 diabetes. Hormone and Metabolic Research 2010; 42:S3–S37.
31. Organisation for Economic Co-operation and Development. Obesity and the Economics of Prevention. Available from: http://dx.doi. org/10.1787/9789264084865-en/content/book/ 9789264084865-en (accessed 6 March 2012).
14. Organisation for Economic Co-operation and Development. OECD Health Ministerial Meeting. Session 2: Healthy Choices. 2010. Available from: http:// www.oecd.org/ dataoecd/14/13/46098333.pdf (accessed 6 March 2012).
32. International Obesity Task Force. EU Platform Briefing Paper. 2005. Available from: http://ec.europa.eu/health/ph_ determinants/life_style/nutrition/ documents/iotf_en.pdf (accessed 6 March 2012).
